首页> 外文期刊>Cancer biology & therapy >Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma
【24h】

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

机译:外显子组测序和数字PCR分析揭示了与胰腺导管腺癌转移相关的新突变基因

获取原文
获取原文并翻译 | 示例
       

摘要

Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers with more than 94% mortality rate mainly due to the widespread metastases. To find out the somatically mutated genes related to the metastasis of PDAC, we analyzed the matched tumor and normal tissue samples from a patient diagnosed with liver metastatic PDAC using intensive exome capture-sequencing analysis ( 170x coverage). Searching for the somatic mutations that drive the clonal expansion of metastasis, we identified 12 genes with higher allele frequencies (AFs) of functional mutations in the metastatic tumor, including known genes KRAS and Tp53 for metastasis. Of the 10 candidate genes, 6 (ADRB1, DCLK1, KCNH2, NOP14, SIGLEC1 and ZC3H7A), together with KRAS and TP53, were clustered into a single network (p value = 1 × 10 -22) that is related to cancer development. Moreover, these candidate genes showed abnormal expression in PDAC tissues and functional impacts on the migration, proliferation and colony formation abilities of pancreatic cancer cell lines. Furthermore, through digital PCR analysis, we revealed potential genomic mechanisms for the KRAS and Tp53 mutations in the metastatic tumor. Taken together, our study shows the possibility for such personalized genomic profiling to provide new biological insight into the metastasis of PDAC.
机译:胰腺导管腺癌(PDAC)是最恶性的癌症之一,其死亡率超过94%,主要是由于广泛的转移。为了找出与PDAC转移相关的体细胞突变基因,我们使用强化的外显子组捕获序列分析(> 170x覆盖率)分析了来自诊断为肝转移性PDAC的患者的匹配肿瘤和正常组织样本。搜索驱动转移的克隆扩展的体细胞突变,我们确定了转移性肿瘤中功能性突变的等位基因频率较高(AFs)的12个基因,包括已知的转移基因KRAS和Tp53。在这10个候选基因中,有6个(ADRB1,DCLK1,KCNH2,NOP14,SIGLEC1和ZC3H7A)以及KRAS和TP53被聚集成与癌症发展相关的单个网络(p值= 1×10 -22)。此外,这些候选基因在PDAC组织中显示异常表达,并对胰腺癌细胞系的迁移,增殖和集落形成能力产生功能性影响。此外,通过数字PCR分析,我们揭示了转移性肿瘤中KRAS和Tp53突变的潜在基因组机制。两者合计,我们的研究表明这种个性化的基因组谱分析的可能性为PDAC的转移提供新的生物学见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号